| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/14/2005 | WO2005033281A2 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | WO2005033274A2 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | WO2005033134A2 Secreted protein therapeutics and uses thereof |
| 04/14/2005 | WO2005033132A2 Igf binding proteins |
| 04/14/2005 | WO2005032496A2 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/14/2005 | WO2005032343A2 Hedgehog signaling in prostate regeneration neoplasia and metastasis |
| 04/14/2005 | WO2005003322A3 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 04/14/2005 | WO2004108890A3 Dilute methanol -or ethanol- induced production of polypeptides in microorganisms |
| 04/14/2005 | WO2004101739A3 Methods for chemically synthesizing immunoglobulin chimeric proteins |
| 04/14/2005 | WO2004073393A3 Immunogene adherence and method of making and using same |
| 04/14/2005 | WO2004067728A3 Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function |
| 04/14/2005 | WO2004031105A3 Use of a33 antigens and jam-it |
| 04/14/2005 | WO2004011485A3 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | WO2003015712A3 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin |
| 04/14/2005 | WO2002079417A3 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 04/14/2005 | US20050080247 Leinamycin biosynthesis gene cluster and its components and their uses |
| 04/14/2005 | US20050080240 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides |
| 04/14/2005 | US20050080237 Oligomeric molecules and uses thereof |
| 04/14/2005 | US20050080233 Expression vector comprising nucleotide sequences coding bacterial outer membrane protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080014 Thrombopoietic compounds |
| 04/14/2005 | US20050080006 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 04/14/2005 | US20050079605 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2005 | US20050079585 Complement depletion using recombinant human C3-derivatives |
| 04/14/2005 | US20050079584 Modified factor VIII |
| 04/14/2005 | US20050079583 Mammalian Zcytor 11 |
| 04/14/2005 | US20050079579 Uses of spatial configuration to modulate protein function |
| 04/14/2005 | US20050079578 Generating transgenic cell which express keratinocyte growth factor-2 (KGF-2) for use ase tool in treatment of ulcers and inflammatory bowel disease |
| 04/14/2005 | US20050079576 Binding polypeptide, for use in the detection and treatment of prostate cancer |
| 04/14/2005 | US20050079575 Human receptor molecules |
| 04/14/2005 | US20050079572 Expression vector comprising nuclelotide sequences coding brain acid soluble protein 1 (BASP1) for use in prevention and treatment of infection, cell proliferative, inflammatory and autoimmune disorders; gene therapy; immunotherapeutics |
| 04/14/2005 | US20050079571 Phosphate limited inducible promoter and a bacillus expression system |
| 04/14/2005 | US20050079550 Isolated protein molecule, flh2882, a GPCR showing homology to the 5HT family of receptors |
| 04/14/2005 | US20050079543 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes |
| 04/14/2005 | US20050079539 Novel gene encoding brain specific membrane protein |
| 04/14/2005 | US20050079538 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; anticarcinogenic agents |
| 04/14/2005 | US20050079537 Expression vector comprising nucleotide sequences coding membrane protein for in identifying modulator for prevention and treatment of cell proliferative, nervous system and inflammatory disorders |
| 04/14/2005 | US20050079525 Long wavelength engineered fluorescent proteins |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079488 For use in expression constructs for expressing gene products, and methods of using it |
| 04/14/2005 | US20050079259 Enzymatic process to produce highly functional soy protein from crude soy material |
| 04/14/2005 | US20050079183 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 04/14/2005 | US20050079177 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 04/14/2005 | US20050079173 Antibody that binds said inhibitor protein; interfering diagnostically or therapeutically with a wnt signal path; treatment of eye disorders, bone disorders, or tumors |
| 04/14/2005 | US20050079169 Anti-FcRn antibodies for treatment of auto/allo immune conditions |
| 04/14/2005 | CA2541823A1 Hypoxia responsive human cngh 0002 genes and polypeptides |
| 04/14/2005 | CA2541018A1 Human prostate cancer cell factor(s) that induce stem cell commitment and osteogenesis |
| 04/14/2005 | CA2541015A1 Igf binding proteins |
| 04/14/2005 | CA2540854A1 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby |
| 04/14/2005 | CA2540667A1 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 04/14/2005 | CA2540665A1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/14/2005 | CA2515583A1 Hydrolases, nucleic acids encoding them and methods for making and using them |
| 04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
| 04/13/2005 | EP1522588A2 Accessory functions for use in recombinant AAV virion production |
| 04/13/2005 | EP1522584A2 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 04/13/2005 | EP1522582A2 Optical sorting method |
| 04/13/2005 | EP1522581A2 Optical sortingmethod |
| 04/13/2005 | EP1522579A2 Hyaluronan synthase gene and uses thereof |
| 04/13/2005 | EP1521849A2 Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof |
| 04/13/2005 | EP1521832A2 Genes |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521773A1 Phosphoinositolglycan (pig)-binding protein from adipocytes |
| 04/13/2005 | EP1521767A2 Methods and constructs for high yield expression of clostripain |
| 04/13/2005 | EP1521594A2 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 04/13/2005 | EP1465912A4 Novel chimeric tnf ligands |
| 04/13/2005 | EP1438425A4 69583 and 85924,novel human protein kinase family members and uses therefor |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1180153B1 Phage-dependent super-production of biologically active proteins and peptides |
| 04/13/2005 | EP1074624B1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene |
| 04/13/2005 | EP0938555B1 Constructs and complexes of cyclin e |
| 04/13/2005 | EP0897988B1 Physiologically active substances tkr1785's, process for the preparation thereof, and microbe |
| 04/13/2005 | EP0741782B1 Methods using eaa3 or eaa4 receptors |
| 04/13/2005 | CN1606627A Corn processing method and useful transgenic plant therein |
| 04/13/2005 | CN1606619A Novel alkaline protease from bacillus gibsonii (DSM 14391) and washing and cleaning agents containing said novel alkaline protease |
| 04/13/2005 | CN1606618A Novel alkali protease formed by bacillus gibsonii (DSM 14393) and washing and cleaning agents containing said novel alkali protease |
| 04/13/2005 | CN1606570A A fusion protein suitable to highly effective expression and production method thereof |
| 04/13/2005 | CN1606569A Human antibodies that have mn binding and cell adhesion-neutralizing activity |
| 04/13/2005 | CN1606567A Antimicrobial polypeptides from pseudoplectania nigrella |
| 04/13/2005 | CN1606565A Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/13/2005 | CN1606453A Cripto blocking antibodies and uses thereof |
| 04/13/2005 | CN1605592A Protease resistant mutein of human ciliary neurotrophic factor and its preparation and use |
| 04/13/2005 | CN1196788C Assembly of wild-type and chimeric influenza virus-like particles (VLPS) |
| 04/13/2005 | CN1196787C Virulence genes and proteins and their use |
| 04/12/2005 | US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 04/12/2005 | US6878816 Vmp-like sequences of pathogenic Borrelia |
| 04/12/2005 | US6878808 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 04/12/2005 | US6878544 Retinal cell lines with extended life-span and their applications |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878376 Modulate immunology response |
| 04/12/2005 | CA2250704C Glial cell line-derived neurotrophic factor receptor |
| 04/12/2005 | CA2113813C Immunoglobulin variants for specific fc epsilon receptors |
| 04/12/2005 | CA2086672C Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 04/12/2005 | CA1341479C Hybrid single-chain plasminogen activators |
| 04/07/2005 | WO2005031309A2 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 04/07/2005 | WO2005030982A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
| 04/07/2005 | WO2005030963A1 Leader sequences for use in production of proteins |
| 04/07/2005 | WO2005030961A1 Novel nerve stem cell marker |
| 04/07/2005 | WO2005030956A1 METHOD OF CLEAVING POLYPEPTIDE BY USING OmpT PROTEASE MUTANT |